Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ARR Stock Summary
Top 10 Correlated ETFs
ARR
In the News

ARMOUR Residential REIT, Inc. (ARR) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Armour Residential REIT (ARR) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

New Strong Sell Stocks for September 14th
AAP, ARR and CBRE have been added to the Zacks Rank #5 (Strong Sell) List on September 14, 2023.

New Strong Sell Stocks for September 8th
ARR, COLM and DNOW have been added to the Zacks Rank #5 (Strong Sell) List on September 8, 2023.

New Strong Sell Stocks for September 6th
AMN, ARR and CFBK have been added to the Zacks Rank #5 (Strong Sell) List on September 6, 2023.

New Strong Sell Stocks for September 1st
AFCG, ARR and ALCO have been added to the Zacks Rank #5 (Strong Sell) List on September 1, 2023.

Armour Residential: No Repo Play, No Problem
Armour Residential REIT, Inc.'s active portfolio is holding up well despite a lack of new repo trade opportunities. We are generally bearish on cyclical credit; however, we believe a heterogeneous opportunity exists in Armour due to its solid execution. A promising haircut line coupled with sound asset yields and receding prepayment risk provides encouragement.

New Strong Sell Stocks for August 29th
ARR, BUSE and FBNC have been added to the Zacks Rank #5 (Strong Sell) List on August 29, 2023.

ARMOUR Residential REIT, Inc. (ARR) Is a Trending Stock: Facts to Know Before Betting on It
Armour Residential REIT (ARR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

ARMOUR Residential: Buy Before The Tide Shifts
ARMOUR Residential primarily invests in government-backed agency MBS, minimizing credit risk. However, the company faces risks from interest rate fluctuations, spread risk, and prepayment risk. ARMOUR Residential is facing challenges in the MBS market, but should benefit greatly when the Fed stops raising rates and spreads normalize.

New Strong Sell Stocks for August 9th
BWA, ARR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on August 9, 2023.
ARR Financial details
ARR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | -1.64 | -3.75 | -0.35 | 0.24 | -1.91 | |
Net income per share | -2.52 | -4.32 | -3.41 | 0.19 | -2.97 | |
Operating cash flow per share | 1.79 | -0.7 | -4.09 | 0.15 | 1.05 | |
Free cash flow per share | 1.79 | -0.7 | -4.09 | 0.15 | 1.05 | |
Cash per share | 172.66 | 209.62 | 84.76 | 4.25 | 0.74 | |
Book value per share | 26.71 | 24.84 | 14.88 | 14.38 | 9.43 | |
Tangible book value per share | 26.71 | 228.88 | 87.53 | 66.34 | 9.43 | |
Share holders equity per share | 26.71 | 24.84 | 14.88 | 14.38 | 9.43 | |
Interest debt per share | 3.66 | 4.98 | 1 | 0.09 | 1.02 | |
Market cap | 863.62M | 1.03B | 680.53M | 779.8M | 664.16M | |
Enterprise value | 641.96M | 852.08M | 512.85M | 441.8M | 576.88M | |
P/E ratio | -8.15 | -4.14 | -3.16 | 50.76 | -1.89 | |
Price to sales ratio | -12.53 | -4.77 | -30.64 | 40.68 | -2.94 | |
POCF ratio | 11.48 | -25.38 | -2.64 | 66.43 | 5.35 | |
PFCF ratio | 11.48 | -25.38 | -2.64 | 66.43 | 5.35 | |
P/B Ratio | 0.77 | 0.72 | 0.73 | 0.68 | 0.6 | |
PTB ratio | 0.77 | 0.72 | 0.73 | 0.68 | 0.6 | |
EV to sales | -9.31 | -3.93 | -23.09 | 23.05 | -2.55 | |
Enterprise value over EBITDA | 13.3 | -3.41 | -2.38 | 28.76 | -5.51 | |
EV to operating cash flow | 8.53 | -20.93 | -1.99 | 37.64 | 4.65 | |
EV to free cash flow | 8.53 | -20.93 | -1.99 | 37.64 | 4.65 | |
Earnings yield | -0.12 | -0.24 | -0.32 | 0.02 | -0.53 | |
Free cash flow yield | 0.09 | -0.04 | -0.38 | 0.02 | 0.19 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -4.59 | 0.73 | 0.78 | -22 | 0.83 | |
Current ratio | 525.81 | 342.27 | 1.28K | 87 | 18.13 | |
Interest coverage | 0.31 | -0.87 | -3.42 | 2.16 | -1 | |
Income quality | -0.71 | 0.16 | 1.2 | 0.76 | -0.54 | |
Dividend Yield | 0.13 | 0.14 | 0.13 | 0.14 | 0.23 | |
Payout ratio | -1.08 | -0.56 | -0.4 | 7.04 | -0.44 | |
Sales general and administrative to revenue | -0.06 | -0.02 | -0.29 | 0.39 | -0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | -0.03 | -0.01 | -0.18 | 0.25 | -0.02 | |
Graham number | 38.88 | 49.15 | 33.79 | 7.91 | 25.12 | |
ROIC | 0.04 | -0.17 | -0.23 | 0.01 | -0.17 | |
Return on tangible assets | -0.01 | -0.02 | -0.04 | 0 | -0.04 | |
Graham Net | -1.16 | 209.46 | 84.85 | 4.3 | -69.64 | |
Working capital | 7.28B | 12.12B | 5.35B | 344M | 109.69M | |
Tangible asset value | 1.13B | 13.24B | 5.52B | 5.27B | 1.11B | |
Net current asset value | -43.17M | 12.12B | 5.35B | 344M | -8.21B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 22.34M | 28.8M | 23.96M | 11.42M | 19.4M | |
Average payables | 11.64M | 24.7M | 19.86M | 4.1M | 16.46M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | -119.18 | -59.12 | -210.93 | 190.4 | -46.55 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 1.66K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | -3.06 | -6.17 | -1.73 | 1.92 | -7.84 | |
Payables turnover | 0 | 0 | 0 | 0 | 0.22 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.09 | -0.17 | -0.23 | 0.01 | -0.32 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | -0.54 | -1.13 | 0.45 | -0.17 | 0.23 | |
Net income per share | -0.55 | -1.17 | -0.27 | -0.72 | 0.22 | |
Operating cash flow per share | 0.09 | 0.73 | 1.35 | 0.29 | -0.04 | |
Free cash flow per share | 0.09 | 0.73 | 1.35 | 0.29 | -0.04 | |
Cash per share | 1.96 | 2.36 | 1.1 | 0.73 | 0.82 | |
Book value per share | 9.13 | 7.66 | 13.99 | 6.58 | 6.46 | |
Tangible book value per share | 9.13 | 7.66 | 13.99 | 6.58 | 62.91 | |
Share holders equity per share | 9.13 | 7.66 | 13.99 | 6.58 | 6.46 | |
Interest debt per share | 0.12 | 0.36 | 0.77 | 0.58 | 0.65 | |
Market cap | 749.86M | 600.23M | 447.53M | 969.08M | 1.06B | |
Enterprise value | 540.72M | 309.44M | 360.24M | 833.64M | 895.32M | |
P/E ratio | -3.2 | -1.04 | -5.18 | -1.82 | 6.16 | |
Price to sales ratio | -13.04 | -4.32 | 12.41 | -31.66 | 23.62 | |
POCF ratio | 75.4 | 6.64 | 4.17 | 17.87 | -118.72 | |
PFCF ratio | 75.4 | 6.64 | 4.17 | 17.87 | -118.72 | |
P/B Ratio | 0.77 | 0.64 | 0.4 | 0.8 | 0.83 | |
PTB ratio | 0.77 | 0.64 | 0.4 | 0.8 | 0.83 | |
EV to sales | -9.41 | -2.22 | 9.99 | -27.23 | 19.97 | |
Enterprise value over EBITDA | -11.87 | -3.09 | 3.43 | -23.32 | 19.92 | |
EV to operating cash flow | 54.37 | 3.42 | 3.35 | 15.38 | -100.36 | |
EV to free cash flow | 54.37 | 3.42 | 3.35 | 15.38 | -100.36 | |
Earnings yield | -0.08 | -0.24 | -0.05 | -0.14 | 0.04 | |
Free cash flow yield | 0.01 | 0.15 | 0.24 | 0.06 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 4.59 | 2.91 | -0.83 | 3.79 | -3.64 | |
Current ratio | 63.3 | 45.73 | 18.13 | 3.32 | 5.31 | |
Interest coverage | -3.5 | -2.26 | 1.45 | -1.3 | 0.35 | |
Income quality | -0.17 | -0.63 | 2.73 | -1.73 | -0.21 | |
Dividend Yield | 0.05 | 0.07 | 0.11 | 0.06 | 0.05 | |
Payout ratio | -0.6 | -0.28 | -2.18 | -0.41 | 1.19 | |
Sales general and administrative to revenue | -0.02 | -0.01 | 0.03 | -0.04 | 0.03 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | -0.02 | -0.01 | 0.02 | -0.02 | 0.02 | |
Graham number | 10.63 | 14.21 | 9.25 | 10.34 | 5.6 | |
ROIC | -0.05 | -0.11 | -0.04 | -0.48 | 0.04 | |
Return on tangible assets | -0.01 | -0.01 | 0 | -0.01 | 0 | |
Graham Net | -68.9 | -71.7 | -103.36 | -64.26 | 0.82 | |
Working capital | 647.53M | 1.38B | 109.69M | 129.39M | 170.04M | |
Tangible asset value | 972.66M | 944.15M | 1.11B | 1.22B | 12.5B | |
Net current asset value | -7.23B | -8.56B | -8.21B | -11.85B | 170.04M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 233.1M | 786.19M | 576.2M | 39.27M | 50.65M | |
Average payables | 8.95M | 20.66M | 29.92M | 42.35M | 47.63M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | -702.65 | -727.04 | 71.92 | -146.2 | 103.53 | |
Days payables outstanding | 567.92 | 1.76K | 408.32 | 4.06K | 1.57K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | -0.13 | -0.12 | 1.25 | -0.62 | 0.87 | |
Payables turnover | 0.16 | 0.05 | 0.22 | 0.02 | 0.06 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.06 | -0.15 | -0.02 | -0.11 | 0.03 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ARR Frequently Asked Questions
What is ARMOUR Residential REIT, Inc. stock symbol ?
ARMOUR Residential REIT, Inc. is a US stock , located in Vero beach of Fl and trading under the symbol ARR
Is ARMOUR Residential REIT, Inc. buy or a sell ?
3 stock analysts have 3 predictions with a medium analyst target price of $11.5. The lowest prediction is $7.5 and the highest is $19
What is ARR stock prediction ?
What is ARMOUR Residential REIT, Inc. stock quote today ?
ARMOUR Residential REIT, Inc. stock price is $4.495 today.
Is ARMOUR Residential REIT, Inc. stock public?
Yes, ARMOUR Residential REIT, Inc. is a publicly traded company.